StonvexLoading…
StonvexStonvexStonvexCore line items from NTES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.11B | $14.43B | $14.57B | $13.99B |
Operating Income | $5.12B | $4.05B | $3.90B | $2.85B |
Net Income | $4.98B | $4.15B | $4.13B | $2.88B |
EPS (Diluted) | $1.50 | $1.26 | $1.27 | $0.89 |
Total Assets | $31.66B | $26.85B | $26.19B | $25.05B |
Total Liabilities | $8.05B | $7.33B | $8.15B | $9.26B |
Cash & Equivalents | $6.74B | $7.04B | $3.02B | $3.61B |
Free Cash Flow OCF − CapEx | $7.10B | $5.26B | $4.65B | $3.71B |
Shares Outstanding | 3.19B | 3.17B | 3.21B | 3.22B |